Effectiveness of Levodopa in Patients with Multiple System Atrophy and Associated Clinicopathological Features.
Conclusion Levodopa responders, despite having MSA-P, may show a relatively slow progression in putaminal neurodegeneration, and might maintain prolonged daily life activities in cases without an early occurrence of autonomic dysfunction.
PMID: 32963152 [PubMed - as supplied by publisher]
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research
More News: Ataxia | Brain | Carbidopa/Levodopa | Internal Medicine | MRI Scan | Neurology | Parkinson's Disease | Pathology | Progressive Supranuclear Palsy